Representatives of Fulgent Genetics to Participate in the Piper Jaffray 30th Annual Healthcare Conference
28 November 2018 - 8:05AM
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the
“company”) today announced that its Chairman and Chief Executive
Officer Ming Hsieh and its Chief Financial Officer Paul Kim are
scheduled to participate in the 30th Annual Piper Jaffray
Healthcare Conference on Wednesday, November 28, 2018 at the Lotte
New York Palace Hotel in New York, New York.
These representatives of the company will
participate in in a question-and-answer session with the host
analyst beginning at approximately 3:00 p.m. ET.
A live webcast of the question and answer
session will be available on the Investor Relations section of the
Fulgent Genetics website at ir.fulgentgenetics.com. A replay
of the webcast will be accessible at ir.fulgentgenetics.com
beginning approximately one hour following the completion of the
event.
About Fulgent Genetics
Fulgent Genetics is a technology company with a
focus on offering comprehensive genetic testing to provide
physicians with clinically actionable diagnostic information they
can use to improve the quality of patient care. The company has
developed a proprietary technology platform that allows it to offer
a broad and flexible test menu and continually expand and improve
its proprietary genetic reference library, while maintaining
accessible pricing, high accuracy and competitive turnaround times.
The company believes its test menu, which currently offers more
genes for testing than its competitors in today’s market, enables
it to provide expansive options for test customization and
clinically actionable results.
Investor Relations Contacts:The
Blueshirt GroupNicole Borsje, 415-217-2633,
nborsje@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Oct 2023 to Oct 2024